Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)

Introduction: Secondary haemophagocytic lymphohistiocytosis (sHLH) or Macrophage Activation Syndrome (MAS) is a life-threatening hyperinflammatory syndrome that can occur in patients with severe infections, malignancy or autoimmune diseases. It is also a rare complication of haematopoetic stem cell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Immunol
Autors principals: Sandler, Robert David, Tattersall, Rachel Scarlett, Schoemans, Helene, Greco, Raffaella, Badoglio, Manuela, Labopin, Myriam, Alexander, Tobias, Kirgizov, Kirill, Rovira, Montserrat, Saif, Muhammad, Saccardi, Riccardo, Delgado, Julio, Peric, Zinaida, Koenecke, Christian, Penack, Olaf, Basak, Grzegorz, Snowden, John Andrew
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Immunology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137396/
https://ncbi.nlm.nih.gov/pubmed/32296434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00524
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars